Table 2 Patient characteristics
From: Steroidogenesis in the adrenal dysfunction of critical illness: impact of etomidate
| Â | Etomidate n = 14 | No etomidate n = 48 | P |
|---|---|---|---|
Age, years | 66 (22) | 67 (17) | 0.36 |
Sex, m/f | 8 (57)/6 (43) | 26 (54)/22 (46) | 1.0 |
Admission syndromes a | Â | Â | Â |
   Trauma and postoperative | 4(29) | 19 (40) | 0.54 |
   Cardiac surgery | 2(14) | 10 (21) | 0.72 |
   Vascular surgery | 0 | 7 (15) | 0.33 |
   Respiratory failure | 9 (64) | 13 (27) | 0.02 |
   Post-CPR | 1 (7) | 9 (19) | 0.43 |
   Shock | 3 (21) | 2 (4) | 0.07 |
   Sepsis | 4 (29) | 15 (31) | 1.0 |
   Renal insufficiency | 0 | 4 (8) | 0.57 |
   Coma | 0 | 4 (8) | 0.57 |
   Other | 3 (21) | 2 (4) | 0.07 |
Start hydrocortisone after first test | |||
Number | 13 (93) | 45 (94) | 1.0 |
Duration, days | 7 (13) | 8 (8) | 0.71 |
Fluconazole/phenytoin | 2 (14) | 4 (8) | 0.62 |
Length of stay ICU, days | 18 (23) | 20 (24) | 0.60 |
Mortality day 28 | 5 (36) | 15 (31) | 0.75 |
Mortality ICU | 5 (36) | 19 (40) | 1.0 |